Igor Bado, PhD

Dr. Bado studies how different tumor microenvironments crosstalk with cancer cells to promote survival, growth, and secondary spread to other organs. His goal is to understand epigenetic implications in cancer cell adaptation, intra-tumoral heterogeneity, and multi-organ metastasis. He believes that epigenetic factors -which modulate gene expression, are key players in the metastatic process and can be targeted to reprogram cancer cells toward improved therapeutic responses. Ultimately, he aims to identify therapeutic vulnerabilities for the long-term remission of metastatic diseases. He uses state-of-the-art approaches to dissect the mechanisms driving breast cancer metastasis from the early dissemination of CTCs to the formation of macro-metastases in advanced stages of the disease.